MDA

One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation—follicular of 5.0-9.9%: Evidence from Malawi

The study demonstrates that in Malawi districts with TF of 5.0–9.9%, one round of azithromycin MDA with 80% coverage associates with a reduction in TF prevalence to <5%.

Subscribe to RSS - MDA